{"url_path":"/sec/repl/8-k/2026-08-11/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K/A","doc_date":"2026-08-11","source_url":"https://www.sec.gov/Archives/edgar/data/1737953/0001104659-26-093512-index.html","accession_number":"0001104659-26-093512","cik":"0001737953","ticker":"REPL","issuer_name":"Replimune Group, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1737953/0001104659-26-093512-index.html","primary_entity_key":"0001737953","primary_entity_name":"Replimune Group, Inc."},"word_count":337,"has_tables":true,"body_markdown":"Item 9.01 Financial Statements and Exhibits.\n\n \n\n**Exhibit No.**\n**Description**\n\n[1.1*](https://www.sec.gov/Archives/edgar/data/1737953/000110465926093042/tm2622673d1_ex1-1.htm)\n[Underwriting Agreement dated August 9, 2026](https://www.sec.gov/Archives/edgar/data/1737953/000110465926093042/tm2622673d1_ex1-1.htm)\n\n[4.1](tm2622780d1_ex4-1.htm)\n[Form of Pre-Funded Warrant](tm2622780d1_ex4-1.htm)\n\n[5.1*](https://www.sec.gov/Archives/edgar/data/1737953/000110465926093042/tm2622673d1_ex5-1.htm)\n[Opinion of Morgan, Lewis & Bockius LLP](https://www.sec.gov/Archives/edgar/data/1737953/000110465926093042/tm2622673d1_ex5-1.htm)\n\n[23.1*](https://www.sec.gov/Archives/edgar/data/1737953/000110465926093042/tm2622673d1_ex5-1.htm)\n[Consent of Morgan, Lewis & Bockius LLP (included in Exhibit 5.1)](https://www.sec.gov/Archives/edgar/data/1737953/000110465926093042/tm2622673d1_ex5-1.htm)\n\n[99.1*](https://www.sec.gov/Archives/edgar/data/1737953/000110465926093042/tm2622673d1_ex99-1.htm)\n[Press Release dated August 10, 2026 announcing the pricing of the Offering](https://www.sec.gov/Archives/edgar/data/1737953/000110465926093042/tm2622673d1_ex99-1.htm)\n\n104\nCover page interactive data file (formatted as Inline XBRL)\n\n \n\n* Previously filed\n\n \n\nForward-Looking Statements\n\n \n\nThis Current Report on Form 8-K\ncontains forward looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E\nof the Securities Exchange Act of 1934, as amended, and that involve risks and uncertainties, including statements regarding the expected\nnet proceeds and the closing date of the Offering and other statements identified by words such as “could,” “expects,”\n“intends,” “may,” “plans,” “potential,” “should,” “will,” “would,”\nor similar expressions and the negatives of those terms. Forward-looking statements are not promises or guarantees of future performance,\nand are subject to a variety of risks and uncertainties, many of which are beyond our control, and which could cause actual results to\ndiffer materially from those contemplated in such forward-looking statements, including, but not limited to, the risks as may be detailed\nfrom time to time in our Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q and other reports we file with the SEC,\nand in the final prospectus supplement and the accompanying prospectus related to the Offering. Our actual results could differ materially\nfrom the results described in or implied by such forward-looking statements. Forward-looking statements speak only as of the date hereof,\nand, except as required by law, we undertake no obligation to update or revise these forward-looking statements.\n\n \n\n3\n\n \n\n \n\nSIGNATURES\n\n \n\nPursuant to the requirements\nof the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned\nhereunto duly authorized.\n\n \n\n \n**REPLIMUNE GROUP, INC.**\n\n \n \n\nDate:  August 11, 2026\nBy:\n/s/ Sushil Patel\n\n \n \nSushil Patel\n\n \n \nChief Executive Officer\n\n \n\n4"}